| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | CA2594411C Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 05/21/2013 | CA2522614C Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 05/21/2013 | CA2478011C Bispecific antibody point mutations for enhancing rate of clearance |
| 05/21/2013 | CA2451109C Infection control system |
| 05/21/2013 | CA2428753C Methods for inhibiting the transmission of hiv using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/16/2013 | WO2013071059A1 Synthetic catalase/superoxide dismutase mimetics and methods for treating viral infections |
| 05/16/2013 | WO2013070910A1 Reducing transmission of sexually transmitted infections |
| 05/16/2013 | WO2013070887A1 Substituted purine nucleosides, phosphoramidate and phosphordiamidate derivatives for treatment of viral infections |
| 05/16/2013 | WO2013070776A1 Neutralizing gp41 antibodies and their use |
| 05/16/2013 | WO2013070586A1 Small molecule modulators of prb inactivation |
| 05/16/2013 | WO2013070118A1 (3k,4k,58)-4-acylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-ene carboxylic acids, esters thereof and method of use |
| 05/16/2013 | WO2013070030A1 Composition containing 3-dodecanoyloxy-2-isobutyryloxy-4-methylpentanoic acid as active ingredient |
| 05/16/2013 | WO2013069780A1 Viral infection preventive |
| 05/16/2013 | WO2013069765A1 Nitrogenated heterocyclic compound |
| 05/16/2013 | WO2013069297A1 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal |
| 05/16/2013 | WO2013068949A1 Carrier molecule comprising a spr0096 and a spr2021 antigen |
| 05/16/2013 | WO2013068847A2 Compositions and methods for treatment of cytomegalovirus |
| 05/16/2013 | WO2013068769A1 Pharmaceutical compounds |
| 05/16/2013 | WO2013068743A1 Novel bacteriophages |
| 05/16/2013 | WO2013068593A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum |
| 05/16/2013 | WO2013068551A1 Disubstituted triazine dimers for treatment and/or prevention of infectious diseases |
| 05/16/2013 | WO2013068458A1 Therapeutically active thiazolo-pyrimidine derivatives |
| 05/16/2013 | WO2013068438A1 Purine derivatives for the treatment of viral infections |
| 05/16/2013 | WO2013067873A1 Anti-influenza virus nucleic acid, peptide nucleic acid and formulation thereof |
| 05/16/2013 | WO2013067769A1 Liquid composition of anti-hepatitis b virus |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | WO2013067608A1 Immunomodulating compound for the treatment of cancerous tumours that are located in the internal and external epithelial tissue |
| 05/16/2013 | WO2013067578A1 Modulators of c3a receptors |
| 05/16/2013 | WO2013042964A3 Novel bacteriophage and antibacterial composition comprising the same |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123742 Method of a Pharmaceutical Delivery System for Use Within a Joint Replacement |
| 05/16/2013 | US20130123741 Flexible sterile bag containing pharmaceutical products and diluant separately and method of making the same |
| 05/16/2013 | US20130123477 Tiacumicin Production |
| 05/16/2013 | US20130122115 Rebound hoof pack |
| 05/16/2013 | US20130122039 V. Cholera hypereexpressing recombinant cholera toxin B subunit showing dual immunogenicity |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | DE102008045194B4 Medizinisches Präparat auf pflanzlicher Basis Medical preparation plant-based |
| 05/16/2013 | CA2858372A1 Compositions and methods for the prevention of microbial infections |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/16/2013 | CA2855372A1 Acc inhibitors and uses thereof |
| 05/16/2013 | CA2855252A1 Influenza virus -like particles (vlps) comprising hemagglutinin produced nicotiana tabacum |
| 05/16/2013 | CA2855204A1 Pharmaceutical compounds |
| 05/16/2013 | CA2855022A1 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal |
| 05/16/2013 | CA2854934A1 Carrier molecule comprising a spr0096 and a spr2021 antigen |
| 05/16/2013 | CA2854817A1 Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| 05/16/2013 | CA2850448A1 Purine derivatives for the treatment of viral infections |
| 05/15/2013 | EP2591802A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
| 05/15/2013 | EP2591797A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 05/15/2013 | EP2591776A1 Use of kukoamine a and kukoamine b |
| 05/15/2013 | EP2591000A2 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 05/15/2013 | EP2590999A1 Lipid-conjugated antibodies |
| 05/15/2013 | EP2590978A2 Carbapenem antibacterials with gram-negative activity |
| 05/15/2013 | EP2590960A1 Heterocyclic antiviral compounds |
| 05/15/2013 | EP2590675A1 Respiratory syncytial virus antigenic compositions and methods |
| 05/15/2013 | EP2590658A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 05/15/2013 | EP2590641A2 Methods of immune modulation |
| 05/15/2013 | EP2590637A1 Propofol for use as an antiviral medicament |
| 05/15/2013 | CN103103205A Gene for encoding recombinant porcine circovirus type 2 (PCV2) Cap protein and application of gene |
| 05/15/2013 | CN103103196A Modified goat defensin gene and preparation method and application thereof |
| 05/15/2013 | CN103103195A Sequence of aptamer for outer membrane protein TolC of escherichia coli and application of sequence |
| 05/15/2013 | CN103103163A Lentogenic CH60 strain of duck virual hepatitis virus and attenuated live vaccine thereof |
| 05/15/2013 | CN103103148A Method for screening Bacillus subtilis applicable to taking corn starch sewage as carbon source of culture medium and production method of wettable powder |
| 05/15/2013 | CN103102397A Peptide nucleic acid for prevention and treatment of PCV2 virus and preparation thereof |
| 05/15/2013 | CN103102396A Novel thiostrepton analog, amd preparation method and application thereof |
| 05/15/2013 | CN103102394A B cell epitope peptide PUHI49 for hepatitis c virus (HCV) and application of B cell epitope peptide PUHI49 |
| 05/15/2013 | CN103102389A Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease |
| 05/15/2013 | CN103102383A Crystal form A of glycyrrhetinic acid-30-amide derivative and preparation method thereof |
| 05/15/2013 | CN103102382A Crystal form B of glycyrrhetinic acid-30-amide derivative and preparation method thereof |
| 05/15/2013 | CN103102377A Novel crystal form of erythromycin A-ring 11,12-carbonic ester, pharmaceutical composition containing novel crystal form B, and application thereof |
| 05/15/2013 | CN103102358A Cephalosporin compound, crystal thereof, and preparation method and application thereof |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof |
| 05/15/2013 | CN103102322A Oxazole compound and preparation method thereof, medicine composition and application thereof |
| 05/15/2013 | CN103102313A Substituted aromatic vinyl imidazole compound and application thereof |
| 05/15/2013 | CN103102302A Quinolinone compound, preparation method and pharmaceutical composition of quinolinone compound and application of pharmaceutical composition |
| 05/15/2013 | CN103100083A Vaccine and preparation method thereof |
| 05/15/2013 | CN103100082A Method for preparing porcine circovirus type 2 inactivated vaccine by utilizing bioreactor |
| 05/15/2013 | CN103100081A Multi-valence combined vaccine |
| 05/15/2013 | CN103100070A Medicine pair preparation made from humulus japonicus and ginger and having effect of cooperatively increasing anti-bacterial diarrhea |
| 05/15/2013 | CN103100069A Adenophora stricta tablets for clearing heat and eliminating phlegm |
| 05/15/2013 | CN103100064A Medicinal liquor for removing genital odor |
| 05/15/2013 | CN103100044A Traditional Chinese medicine pill for treating cervical tuberculous lymphadenitis |
| 05/15/2013 | CN103100014A Traditional Chinese medicine for treating beriberi |
| 05/15/2013 | CN103100007A Traditional Chinese medicine composition used for treating human papillomavirus infection as well as preparation method and application thereof |
| 05/15/2013 | CN103100002A Medicament for treating acute herpes zoster caused by retention of damp-heat in the interior |
| 05/15/2013 | CN103099946A Pharmaceutical composition for anti-inflammation and preparation method thereof |
| 05/15/2013 | CN103099921A Broad-spectrum antitoxic bacteriostatic veterinary drug and production method thereof |
| 05/15/2013 | CN103099902A Traditional Chinese medicine composition for treating subacute thyroiditis and preparation method thereof |
| 05/15/2013 | CN103099871A Medicine treating dysentery and its preparation method |
| 05/15/2013 | CN103099857A Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof |
| 05/15/2013 | CN103099854A Application of Shenkang injection in preparing drug for preventing and treating cardiovascular and cerebrovascular diseases |
| 05/15/2013 | CN103099852A Chinese herbal medicine product for treating hepatitis B |
| 05/15/2013 | CN103099851A Pharmaceutical composition for treating cold and preparation method thereof |
| 05/15/2013 | CN103099846A Poultry and livestock drug |
| 05/15/2013 | CN103099845A Method for extracting perillaseed hydrophilic chemical component from perillaseed oil residue |
| 05/15/2013 | CN103099841A Traditional Chinese medicinal composition for treatment of hepatitis |
| 05/15/2013 | CN103099838A Anti-hepatitis B virus composition taken from fresh dandelion and application of anti-hepatitis B virus composition in preparation of anti-hepatitis B virus drug |